Who are Urotronic's investors?

Urotronic's investors include HM Venture Partners.

How much funding has Urotronic raised?

Urotronic has disclosed $38.5M raised across 3 rounds.

Where is Urotronic headquartered?

Urotronic is headquartered in Plymouth, US.

Urotronic

Plymouth, US · Founded 2014 · Delaware corporation · 1 known investors

Urotronic develops drug-coated balloons for interventional urology, including the Optilume products for treating benign prostatic hyperplasia (BPH) and urethral strictures. Its devices are marketed to physicians and patients in the urology field.

Healthtech Medical Devices

Founders & leadership

Junfeng WangNamed on SEC filing

David PerryNamed on SEC filing

Tan ChingNamed on SEC filing

Hui HuNamed on SEC filing

Lixiao WangNamed on SEC filing

Doug KohrsNamed on SEC filing

Investors · 1

HM Venture PartnersSan Francisco

Reported raises · per SEC filings

Form D private placements

$38.5M disclosed across 3 rounds · 2018–2020

▶$12.4MraisedOct 2020 · 26 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Jeff ThomasDirector
Rushu LuoDirector
Doug KohrsDirector
Junfeng WangDirector
Yuriy PrilutskiyDirector
Lixiao WangDirector, Promoter
Hui HuDirector, Promoter
David PerryExecutive Officer, Director
Tan ChingDirector

Offering amount: $19.9M
Amount sold: $12.4M
First sale: Oct 2020
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$20MraisedAug 2018 · 7 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Junfeng WangDirector
Doug KohrsDirector
Tan ChingDirector
David PerryExecutive Officer, Director
Lixiao WangDirector, Promoter
Hui HuDirector, Promoter
Rushu LuoDirector

Offering amount: $20M
Amount sold: $20M
First sale: Aug 2018
Incorporated: Corporation, Delaware, 2014
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$6.1MraisedJul 2018 · 21 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Junfeng WangDirector
David PerryExecutive Officer, Director
Tan ChingDirector
Hui HuDirector, Promoter
Lixiao WangDirector, Promoter
Doug KohrsDirector

Offering amount: $6.1M
Amount sold: $6.1M
Proceeds to insiders: $285.5K
First sale: Mar 2018
Incorporated: Corporation, Delaware, 2014
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Laborie39 shared keywordsLaborie is a specialist medical device company that develops technologies for diagnosing and treating pelvic and gastrointestinal conditions and for supporting safe deliveries for mothers and babies. It serves healthcare professionals and works with clinicians, universities, and non-profits, offering educational resources alongside its products.

Companies competing with Urotronic for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Urotronic do?: Urotronic develops drug-coated balloons for interventional urology, including the Optilume products for treating benign prostatic hyperplasia (BPH) and urethral strictures. Its devices are marketed to physicians and patients in the urology field.
Who are Urotronic's investors?: Urotronic's investors include HM Venture Partners.
How much funding has Urotronic raised?: Urotronic has disclosed $38.5M raised across 3 rounds.
Where is Urotronic headquartered?: Urotronic is headquartered in Plymouth, US.